About Us

FabRx was created by leading academics at University College London (UCL), with  a passion for developing better medicines using 3D printing. We believe in a world where medical treatment can be personalised to the individual needs of each patient (in terms of dosage, shape, size and dose combinations) for production on site in pharmacies or clinical trials units. In this way, medicine taking is easier, more effective and associated with better patient outcomes.

Established in 2014, FabRx is a small start-up company with a big vision. Using our patented technologies, we provide a novel and flexible platform for the production of personalised medicines, revolutionising medical treatment for patients around the world. The future of medicine is 3D.


Meet The Team

Alvaro Goyanes

Founding Partner and CEO

Dr Alvaro Goyanes is the CEO and lead project researcher at FabRx. Alvaro holds a PhD in pharmaceutical technology and has more than 10 years’ experience in Pharmaceutics spanning Industry and Academia. He was one of the first researchers assessing opportunities of 3D printing using Fused Deposition Modeling (FDM) to manufacture oral dosage forms and medical devices. Before moving to FabRx, he was a Postdoctoral Researcher at UCL School of Pharmacy researching about 3D printed medicines for oral drug delivery. He led also formulation development projects for pharmaceutical companies and managed multiple research projects of MSc and Ph.D. students evaluating multiple technologies for drug delivery. Prior to this, he worked for 3 years as a Registered Pharmacy, thus has first-hand knowledge of the needs in terms of medicines in the community pharmacy.

Bill Lindsay

Founding Partner and Director

Dr Bill Lindsay trained as a molecular biologist at the University of Oxford and at the Salk Institute in San Diego, before moving to commercial roles within Thermo Corporation, rising to Director of New Products in the Molecular Biology Division. In 2004 Bill moved into university technology transfer having business management roles with the School of Pharmacy, London and with University College London where he was responsible for multiple technology licences and the establishment of a number of successful spin-out companies. In 2016 Bill co-founded Intract Pharma, a spin-out from UCL and led Intract as CEO, building the company into a substantial technology development and licensing business before moving in 2022 into a part-time business supporting role while in parallel holding an executive position as Director of Business for FabRx, a company which he co-founded. Bill has been involved in many types of business transaction, from licensing and spin-out company formation to corporate merger and acquisition.

Abdul Basit

Founding Partner and Director

Professor Abdul Basit is the Formulation Director at FabRx and he holds the position of Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul's research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He is an international authority on oral drug delivery and absorption, and has published over 300 papers, book chapters, abstracts, and patents. He leads a large and multi-disciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late stage clinical trials, his commercial view led to the creation of a drug delivery company, Intract Pharma. Abdul was the recipient of several awards including the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS), and is the only non-North American scientist to receive this award. He is a frequent speaker at international conferences, serves as a consultant to numerous pharmaceutical companies and is on the advisory boards of healthcare organizations, charitable bodies and scientific journals.

Anna Worsley

Director of Innovation

Anna Worsley joined FabRx in May 2021 as a Senior Formulation Scientist. Prior to this she completed her PhD in Biomaterials for Diabetic Chronic Wounds at The Royal Veterinary College and University College London (UCL), her MSc in Nanotechnology and Regenerative Medicine from UCL, and her BSc in Anatomy and Human Biology from The University of Liverpool. During her PhD, Anna completed two internships in industry as a medical writer and R&D chemist. She also obtained a place on the Medtech Superconnector Programme, offering business training and additional funding for project continuation after her PhD. Anna hopes to use her varied experiences to support the advancement of FabRx, both with novel formulations and business growth.

Carlos Rial

Lead Software Engineer

Carlos Rial joined FabRx in 2020 as a software engineer. He holds a Computer Engineering degree from the University of Santiago de Compostela and a Masters in Development of Web Applications and Services from the International University of Valencia. For his thesis, Carlos developed a software system for printing scaled data matrix codes which meet patient dose requirements and contain information that can later be consulted using a mobile device. During this time, he also undertook an internship at Altia Consultores as a business intelligence consultant where he took part in a project to improve the company's decision making processes. Carlos has been involved in many published projects related to pharmaceutical 3D printing using various technologies, including the development of software artifacts to control a volumetric 3D printer for rapid production of medicines, and a smartphone-enabled 3D printing of medicines.

André Campos

Senior Software Engineer

André Campos holds a Computer Engineering degree from the University of Santiago de Compostela. He participated in an internship program at Gradiant, ICT R&D centre where he took part in a project about retrieving and analyzing information from social media. He completed his degree thesis on the development of an app for estimating the levels of drugs in saliva using colorimetric methods. He is currently studying a master’s degree in Big Data in the University of Santiago de Compostela.

Carlos Bendicho

Senior Formulation Scientist

Carlos holds a MPharm degree from the University of Santiago de Compostela. He completed a research traineeship at Cardiff University where he was involved in a research project at the School of Optometry and Vision Science. He previously worked for 5 years as a registered pharmacist in the Spanish National Healthcare System where he tutored trainees and gained experience in running a community pharmacy. He is currently completing his PhD in pharmaceutical technology at the University of Santiago de Compostela where he is developing polymeric intravitreal implants loaded with monoclonal antibodies for age-related macular degeneration, involving the fabrication of moulds using 3D printing and the processing of the implant using supercritical fluid technology.

Brais Iglesias

Electronics and Automation Engineer

Brais Iglesias holds a Bachelor's Degree in Industrial Technologies Engineering and a Bachelor's Degree in Industrial Electronics and Automation Engineering from the University of Vigo. He completed his degree thesis in collaboration with Enel on the application of Machine Learning algorithms for preventive maintenance in wind turbines. He also developed a Machine Learning algorithm to prevent alcohol abuse among teenagers and has experience in robotics from university and personal projects. He is currently studying a Master's Degree in Mechatronics at the University of Vigo, set to graduate in 2023.

Copyright © 2022 FabRx Ltd